WallStSmart
IBIO

iBio, Inc. Common Stock

NASDAQ: IBIO · HEALTHCARE · BIOTECHNOLOGY

$1.59
-5.92% today

Updated 2026-05-01

Market cap
$57.47M
P/E ratio
P/S ratio
191.56x
EPS (TTM)
$-1.00
Dividend yield
52W range
$1 – $4
Volume
1.0M

iBio, Inc. Common Stock (IBIO) Financial statements

SEC filings — annual and quarterly data.

Cash flow — annual

Item2007200820092010201120122013201420152016201720182019202020212022202320242025
Operating cash flow$-849378.00$-1.15M$-2.02M$-2.35M$-5.34M$-6.01M$-4.85M$-4.12M$-4.72M$-8.07M$-13.16M$-13.48M$-13.97M$-13.35M$-30.06M$-37.80M$-30.44M$-18.55M$-15.30M
Capital expenditures$809645.00$287815.00$1.61M$576976.00$94088.00$245100.00$195000.00$259000.00$215000.00$68000.00$1.59M$1.08M$990000.00$1.15M$5.16M$7.33M$5.74M$210000.00$16000.00
Depreciation
Stock-based comp$13059.00$143828.00$2.79M$2.68M$1.26M$1.07M$914000.00$1.25M$1.01M$770000.00$241000.00$388000.00$1.59M$4.38M$4.39M$2.04M$1.53M
Free cash flow$-1.66M$-1.44M$-3.64M$-2.93M$-5.43M$-6.25M$-5.04M$-4.38M$-4.94M$-8.14M$-14.76M$-14.56M$-14.96M$-14.50M$-35.23M$-45.13M$-36.17M$-18.76M$-15.32M
Investing cash flow
Financing cash flow
Dividends paid$0.00$0.00$0.00$0.00$0.00$0.00$21.56M$500000.00
Share repurchases
Debt repayment
Net change in cash$2.78M$-1.21M$-824000.00$5.90M$13.52M$-14.93M$7.85M$-11.51M$50.69M